 | • レポートコード：MRC2012B0330 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、エンジニアードT細胞の世界市場を広く調査・分析し、今後の市場展望をまとめております。エンジニアードT細胞の種類別市場規模（腫瘍浸潤リンパ球、T細胞受容体{TCR}、キメラ抗原受容体（CAR））、用途別市場規模（病院、がん研究センター、クリニック）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Autolus Limited、Oxford Biomedica、Elli Lilly and Company、Bellicum Pharmaceuticals、Novartis、Cells Medica、Precision Bioscience、Juno Therapeutics、Gilead Sciences、Pfizer、Redmile Group、Seeking Alpha、Unum Therapeutics、 ・地域別グローバル市場分析 2015年-2020年 ・エンジニアードT細胞の北米市場（アメリカ、カナダ、メキシコ） ・エンジニアードT細胞のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・エンジニアードT細胞のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・エンジニアードT細胞の南米市場（ブラジル、アルゼンチン） ・エンジニアードT細胞の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：腫瘍浸潤リンパ球、T細胞受容体{TCR}、キメラ抗原受容体（CAR） ・用途別分析：病院、がん研究センター、クリニック ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Engineered T Cells market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 25.2% in the forecast period of 2020 to 2025 and will expected to reach USD 666.1 million by 2025, from USD 270.8 million in 2019.
The Engineered T Cells market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Engineered T Cells market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Engineered T Cells market has been segmented into:
Tumor Infiltrating Lymphocytes
T Cell Receptor {TCR}
Chimeric Antigen Receptor (CAR)
By Application, Engineered T Cells has been segmented into:
Hospitals
Cancer Research Centers
Clinics
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Engineered T Cells market presented in the report. This section sheds light on the sales growth of different regional and country-level Engineered T Cells markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Engineered T Cells market.
The report offers in-depth assessment of the growth and other aspects of the Engineered T Cells market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Engineered T Cells Market Share Analysis
Engineered T Cells competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Engineered T Cells sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Engineered T Cells sales, revenue and market share for each player covered in this report.
The major players covered in Engineered T Cells are:
Autolus Limited
Oxford Biomedica
Elli Lilly and Company
Bellicum Pharmaceuticals
Novartis
Cells Medica
Precision Bioscience
Juno Therapeutics
Gilead Sciences
Pfizer
Redmile Group
Seeking Alpha
Unum Therapeutics
Table of Contents
1 Engineered T Cells Market Overview
1.1 Product Overview and Scope of Engineered T Cells
1.2 Classification of Engineered T Cells by Type
1.2.1 Global Engineered T Cells Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Engineered T Cells Revenue Market Share by Type in 2019
1.2.3 Tumor Infiltrating Lymphocytes
1.2.4 T Cell Receptor {TCR}
1.2.5 Chimeric Antigen Receptor (CAR)
1.3 Global Engineered T Cells Market by Application
1.3.1 Overview: Global Engineered T Cells Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Cancer Research Centers
1.3.4 Clinics
1.4 Global Engineered T Cells Market by Regions
1.4.1 Global Engineered T Cells Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Engineered T Cells (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Engineered T Cells Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Engineered T Cells Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Engineered T Cells Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Engineered T Cells Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Engineered T Cells Status and Prospect (2015-2025)
2 Company Profiles
2.1 Autolus Limited
2.1.1 Autolus Limited Details
2.1.2 Autolus Limited Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Autolus Limited SWOT Analysis
2.1.4 Autolus Limited Product and Services
2.1.5 Autolus Limited Engineered T Cells Revenue, Gross Margin and Market Share (2018-2019)
2.2 Oxford Biomedica
2.2.1 Oxford Biomedica Details
2.2.2 Oxford Biomedica Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Oxford Biomedica SWOT Analysis
2.2.4 Oxford Biomedica Product and Services
2.2.5 Oxford Biomedica Engineered T Cells Revenue, Gross Margin and Market Share (2018-2019)
2.3 Elli Lilly and Company
2.3.1 Elli Lilly and Company Details
2.3.2 Elli Lilly and Company Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Elli Lilly and Company SWOT Analysis
2.3.4 Elli Lilly and Company Product and Services
2.3.5 Elli Lilly and Company Engineered T Cells Revenue, Gross Margin and Market Share (2018-2019)
2.4 Bellicum Pharmaceuticals
2.4.1 Bellicum Pharmaceuticals Details
2.4.2 Bellicum Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Bellicum Pharmaceuticals SWOT Analysis
2.4.4 Bellicum Pharmaceuticals Product and Services
2.4.5 Bellicum Pharmaceuticals Engineered T Cells Revenue, Gross Margin and Market Share (2018-2019)
2.5 Novartis
2.5.1 Novartis Details
2.5.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Novartis SWOT Analysis
2.5.4 Novartis Product and Services
2.5.5 Novartis Engineered T Cells Revenue, Gross Margin and Market Share (2018-2019)
2.6 Cells Medica
2.6.1 Cells Medica Details
2.6.2 Cells Medica Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Cells Medica SWOT Analysis
2.6.4 Cells Medica Product and Services
2.6.5 Cells Medica Engineered T Cells Revenue, Gross Margin and Market Share (2018-2019)
2.7 Precision Bioscience
2.7.1 Precision Bioscience Details
2.7.2 Precision Bioscience Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Precision Bioscience SWOT Analysis
2.7.4 Precision Bioscience Product and Services
2.7.5 Precision Bioscience Engineered T Cells Revenue, Gross Margin and Market Share (2018-2019)
2.8 Juno Therapeutics
2.8.1 Juno Therapeutics Details
2.8.2 Juno Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Juno Therapeutics SWOT Analysis
2.8.4 Juno Therapeutics Product and Services
2.8.5 Juno Therapeutics Engineered T Cells Revenue, Gross Margin and Market Share (2018-2019)
2.9 Gilead Sciences
2.9.1 Gilead Sciences Details
2.9.2 Gilead Sciences Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Gilead Sciences SWOT Analysis
2.9.4 Gilead Sciences Product and Services
2.9.5 Gilead Sciences Engineered T Cells Revenue, Gross Margin and Market Share (2018-2019)
2.10 Pfizer
2.10.1 Pfizer Details
2.10.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Pfizer SWOT Analysis
2.10.4 Pfizer Product and Services
2.10.5 Pfizer Engineered T Cells Revenue, Gross Margin and Market Share (2018-2019)
2.11 Redmile Group
2.11.1 Redmile Group Details
2.11.2 Redmile Group Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Redmile Group SWOT Analysis
2.11.4 Redmile Group Product and Services
2.11.5 Redmile Group Engineered T Cells Revenue, Gross Margin and Market Share (2018-2019)
2.12 Seeking Alpha
2.12.1 Seeking Alpha Details
2.12.2 Seeking Alpha Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Seeking Alpha SWOT Analysis
2.12.4 Seeking Alpha Product and Services
2.12.5 Seeking Alpha Engineered T Cells Revenue, Gross Margin and Market Share (2018-2019)
2.13 Unum Therapeutics
2.13.1 Unum Therapeutics Details
2.13.2 Unum Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Unum Therapeutics SWOT Analysis
2.13.4 Unum Therapeutics Product and Services
2.13.5 Unum Therapeutics Engineered T Cells Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Engineered T Cells Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Engineered T Cells Players Market Share
3.2.2 Top 10 Engineered T Cells Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Engineered T Cells Revenue and Market Share by Regions
4.2 North America Engineered T Cells Revenue and Growth Rate (2015-2020)
4.3 Europe Engineered T Cells Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Engineered T Cells Revenue and Growth Rate (2015-2020)
4.5 South America Engineered T Cells Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Engineered T Cells Revenue and Growth Rate (2015-2020)
5 North America Engineered T Cells Revenue by Countries
5.1 North America Engineered T Cells Revenue by Countries (2015-2020)
5.2 USA Engineered T Cells Revenue and Growth Rate (2015-2020)
5.3 Canada Engineered T Cells Revenue and Growth Rate (2015-2020)
5.4 Mexico Engineered T Cells Revenue and Growth Rate (2015-2020)
6 Europe Engineered T Cells Revenue by Countries
6.1 Europe Engineered T Cells Revenue by Countries (2015-2020)
6.2 Germany Engineered T Cells Revenue and Growth Rate (2015-2020)
6.3 UK Engineered T Cells Revenue and Growth Rate (2015-2020)
6.4 France Engineered T Cells Revenue and Growth Rate (2015-2020)
6.5 Russia Engineered T Cells Revenue and Growth Rate (2015-2020)
6.6 Italy Engineered T Cells Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Engineered T Cells Revenue by Countries
7.1 Asia-Pacific Engineered T Cells Revenue by Countries (2015-2020)
7.2 China Engineered T Cells Revenue and Growth Rate (2015-2020)
7.3 Japan Engineered T Cells Revenue and Growth Rate (2015-2020)
7.4 Korea Engineered T Cells Revenue and Growth Rate (2015-2020)
7.5 India Engineered T Cells Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Engineered T Cells Revenue and Growth Rate (2015-2020)
8 South America Engineered T Cells Revenue by Countries
8.1 South America Engineered T Cells Revenue by Countries (2015-2020)
8.2 Brazil Engineered T Cells Revenue and Growth Rate (2015-2020)
8.3 Argentina Engineered T Cells Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Engineered T Cells by Countries
9.1 Middle East & Africa Engineered T Cells Revenue by Countries (2015-2020)
9.2 Saudi Arabia Engineered T Cells Revenue and Growth Rate (2015-2020)
9.3 UAE Engineered T Cells Revenue and Growth Rate (2015-2020)
9.4 Egypt Engineered T Cells Revenue and Growth Rate (2015-2020)
9.5 South Africa Engineered T Cells Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Engineered T Cells Revenue and Market Share by Type (2015-2020)
10.2 Global Engineered T Cells Market Forecast by Type (2019-2024)
10.3 Tumor Infiltrating Lymphocytes Revenue Growth Rate (2015-2025)
10.4 T Cell Receptor {TCR} Revenue Growth Rate (2015-2025)
10.5 Chimeric Antigen Receptor (CAR) Revenue Growth Rate (2015-2025)
11 Global Engineered T Cells Market Segment by Application
11.1 Global Engineered T Cells Revenue Market Share by Application (2015-2020)
11.2 Engineered T Cells Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Cancer Research Centers Revenue Growth (2015-2020)
11.5 Clinics Revenue Growth (2015-2020)
12 Global Engineered T Cells Market Size Forecast (2021-2025)
12.1 Global Engineered T Cells Market Size Forecast (2021-2025)
12.2 Global Engineered T Cells Market Forecast by Regions (2021-2025)
12.3 North America Engineered T Cells Revenue Market Forecast (2021-2025)
12.4 Europe Engineered T Cells Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Engineered T Cells Revenue Market Forecast (2021-2025)
12.6 South America Engineered T Cells Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Engineered T Cells Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Engineered T Cells Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Engineered T Cells by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Engineered T Cells Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Engineered T Cells Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Autolus Limited Corporate Information, Location and Competitors
Table 6. Autolus Limited Engineered T Cells Major Business
Table 7. Autolus Limited Engineered T Cells Total Revenue (USD Million) (2017-2018)
Table 8. Autolus Limited SWOT Analysis
Table 9. Autolus Limited Engineered T Cells Product and Solutions
Table 10. Autolus Limited Engineered T Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Oxford Biomedica Corporate Information, Location and Competitors
Table 12. Oxford Biomedica Engineered T Cells Major Business
Table 13. Oxford Biomedica Engineered T Cells Total Revenue (USD Million) (2018-2019)
Table 14. Oxford Biomedica SWOT Analysis
Table 15. Oxford Biomedica Engineered T Cells Product and Solutions
Table 16. Oxford Biomedica Engineered T Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Elli Lilly and Company Corporate Information, Location and Competitors
Table 18. Elli Lilly and Company Engineered T Cells Major Business
Table 19. Elli Lilly and Company Engineered T Cells Total Revenue (USD Million) (2017-2018)
Table 20. Elli Lilly and Company SWOT Analysis
Table 21. Elli Lilly and Company Engineered T Cells Product and Solutions
Table 22. Elli Lilly and Company Engineered T Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Bellicum Pharmaceuticals Corporate Information, Location and Competitors
Table 24. Bellicum Pharmaceuticals Engineered T Cells Major Business
Table 25. Bellicum Pharmaceuticals Engineered T Cells Total Revenue (USD Million) (2017-2018)
Table 26. Bellicum Pharmaceuticals SWOT Analysis
Table 27. Bellicum Pharmaceuticals Engineered T Cells Product and Solutions
Table 28. Bellicum Pharmaceuticals Engineered T Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Novartis Corporate Information, Location and Competitors
Table 30. Novartis Engineered T Cells Major Business
Table 31. Novartis Engineered T Cells Total Revenue (USD Million) (2017-2018)
Table 32. Novartis SWOT Analysis
Table 33. Novartis Engineered T Cells Product and Solutions
Table 34. Novartis Engineered T Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Cells Medica Corporate Information, Location and Competitors
Table 36. Cells Medica Engineered T Cells Major Business
Table 37. Cells Medica Engineered T Cells Total Revenue (USD Million) (2017-2018)
Table 38. Cells Medica SWOT Analysis
Table 39. Cells Medica Engineered T Cells Product and Solutions
Table 40. Cells Medica Engineered T Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Precision Bioscience Corporate Information, Location and Competitors
Table 42. Precision Bioscience Engineered T Cells Major Business
Table 43. Precision Bioscience Engineered T Cells Total Revenue (USD Million) (2017-2018)
Table 44. Precision Bioscience SWOT Analysis
Table 45. Precision Bioscience Engineered T Cells Product and Solutions
Table 46. Precision Bioscience Engineered T Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Juno Therapeutics Corporate Information, Location and Competitors
Table 48. Juno Therapeutics Engineered T Cells Major Business
Table 49. Juno Therapeutics Engineered T Cells Total Revenue (USD Million) (2017-2018)
Table 50. Juno Therapeutics SWOT Analysis
Table 51. Juno Therapeutics Engineered T Cells Product and Solutions
Table 52. Juno Therapeutics Engineered T Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Gilead Sciences Corporate Information, Location and Competitors
Table 54. Gilead Sciences Engineered T Cells Major Business
Table 55. Gilead Sciences Engineered T Cells Total Revenue (USD Million) (2017-2018)
Table 56. Gilead Sciences SWOT Analysis
Table 57. Gilead Sciences Engineered T Cells Product and Solutions
Table 58. Gilead Sciences Engineered T Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Pfizer Corporate Information, Location and Competitors
Table 60. Pfizer Engineered T Cells Major Business
Table 61. Pfizer Engineered T Cells Total Revenue (USD Million) (2017-2018)
Table 62. Pfizer SWOT Analysis
Table 63. Pfizer Engineered T Cells Product and Solutions
Table 64. Pfizer Engineered T Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Redmile Group Corporate Information, Location and Competitors
Table 66. Redmile Group Engineered T Cells Major Business
Table 67. Redmile Group Engineered T Cells Total Revenue (USD Million) (2017-2018)
Table 68. Redmile Group SWOT Analysis
Table 69. Redmile Group Engineered T Cells Product and Solutions
Table 70. Redmile Group Engineered T Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Seeking Alpha Corporate Information, Location and Competitors
Table 72. Seeking Alpha Engineered T Cells Major Business
Table 73. Seeking Alpha Engineered T Cells Total Revenue (USD Million) (2017-2018)
Table 74. Seeking Alpha SWOT Analysis
Table 75. Seeking Alpha Engineered T Cells Product and Solutions
Table 76. Seeking Alpha Engineered T Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Unum Therapeutics Corporate Information, Location and Competitors
Table 78. Unum Therapeutics Engineered T Cells Major Business
Table 79. Unum Therapeutics Engineered T Cells Total Revenue (USD Million) (2017-2018)
Table 80. Unum Therapeutics SWOT Analysis
Table 81. Unum Therapeutics Engineered T Cells Product and Solutions
Table 82. Unum Therapeutics Engineered T Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Global Engineered T Cells Revenue (Million USD) by Players (2015-2020)
Table 84. Global Engineered T Cells Revenue Share by Players (2015-2020)
Table 85. Global Engineered T Cells Revenue (Million USD) by Regions (2015-2020)
Table 86. Global Engineered T Cells Revenue Market Share by Regions (2015-2020)
Table 87. North America Engineered T Cells Revenue by Countries (2015-2020)
Table 88. North America Engineered T Cells Revenue Market Share by Countries (2015-2020)
Table 89. Europe Engineered T Cells Revenue (Million USD) by Countries (2015-2020)
Table 90. Asia-Pacific Engineered T Cells Revenue (Million USD) by Countries (2015-2020)
Table 91. South America Engineered T Cells Revenue by Countries (2015-2020)
Table 92. South America Engineered T Cells Revenue Market Share by Countries (2015-2020)
Table 93. Middle East and Africa Engineered T Cells Revenue (Million USD) by Countries (2015-2020)
Table 94. Middle East and Africa Engineered T Cells Revenue Market Share by Countries (2015-2020)
Table 95. Global Engineered T Cells Revenue (Million USD) by Type (2015-2020)
Table 96. Global Engineered T Cells Revenue Share by Type (2015-2020)
Table 97. Global Engineered T Cells Revenue Forecast by Type (2021-2025)
Table 98. Global Engineered T Cells Revenue by Application (2015-2020)
Table 99. Global Engineered T Cells Revenue Share by Application (2015-2020)
Table 100. Global Engineered T Cells Revenue Forecast by Application (2021-2025)
Table 101. Global Engineered T Cells Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Engineered T Cells Picture
Figure 2. Global Engineered T Cells Revenue Market Share by Type in 2019
Figure 3. Tumor Infiltrating Lymphocytes Picture
Figure 4. T Cell Receptor {TCR} Picture
Figure 5. Chimeric Antigen Receptor (CAR) Picture
Figure 6. Engineered T Cells Revenue Market Share by Application in 2019
Figure 7. Hospitals Picture
Figure 8. Cancer Research Centers Picture
Figure 9. Clinics Picture
Figure 10. Global Engineered T Cells Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America Engineered T Cells Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe Engineered T Cells Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific Engineered T Cells Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America Engineered T Cells Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa Engineered T Cells Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Engineered T Cells Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Engineered T Cells Revenue Share by Players in 2019
Figure 18. Global Top 5 Players Engineered T Cells Revenue Market Share in 2019
Figure 19. Global Top 10 Players Engineered T Cells Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global Engineered T Cells Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global Engineered T Cells Revenue Market Share by Regions (2015-2020)
Figure 23. Global Engineered T Cells Revenue Market Share by Regions in 2018
Figure 24. North America Engineered T Cells Revenue and Growth Rate (2015-2020)
Figure 25. Europe Engineered T Cells Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific Engineered T Cells Revenue and Growth Rate (2015-2020)
Figure 27. South America Engineered T Cells Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa Engineered T Cells Revenue and Growth Rate (2015-2020)
Figure 29. North America Engineered T Cells Revenue Market Share by Countries (2015-2020)
Figure 30. North America Engineered T Cells Revenue Market Share by Countries in 2019
Figure 31. USA Engineered T Cells Revenue and Growth Rate (2015-2020)
Figure 32. Canada Engineered T Cells Revenue and Growth Rate (2015-2020)
Figure 33. Mexico Engineered T Cells Revenue and Growth Rate (2015-2020)
Figure 34. Europe Engineered T Cells Revenue Market Share by Countries (2015-2020)
Figure 35. Europe Engineered T Cells Revenue Market Share by Countries in 2019
Figure 36. Germany Engineered T Cells Revenue and Growth Rate (2015-2020)
Figure 37. UK Engineered T Cells Revenue and Growth Rate (2015-2020)
Figure 38. France Engineered T Cells Revenue and Growth Rate (2015-2020)
Figure 39. Russia Engineered T Cells Revenue and Growth Rate (2015-2020)
Figure 40. Italy Engineered T Cells Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Engineered T Cells Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific Engineered T Cells Revenue Market Share by Countries in 2019
Figure 43. China Engineered T Cells Revenue and Growth Rate (2015-2020)
Figure 44. Japan Engineered T Cells Revenue and Growth Rate (2015-2020)
Figure 45. Korea Engineered T Cells Revenue and Growth Rate (2015-2020)
Figure 46. India Engineered T Cells Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia Engineered T Cells Revenue and Growth Rate (2015-2020)
Figure 48. South America Engineered T Cells Revenue Market Share by Countries (2015-2020)
Figure 49. South America Engineered T Cells Revenue Market Share by Countries in 2019
Figure 50. Brazil Engineered T Cells Revenue and Growth Rate (2015-2020)
Figure 51. Argentina Engineered T Cells Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa Engineered T Cells Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa Engineered T Cells Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia Engineered T Cells Revenue and Growth Rate (2015-2020)
Figure 55. UAE Engineered T Cells Revenue and Growth Rate (2015-2020)
Figure 56. Egypt Engineered T Cells Revenue and Growth Rate (2015-2020)
Figure 57. South Africa Engineered T Cells Revenue and Growth Rate (2015-2020)
Figure 58. Global Engineered T Cells Revenue Share by Type (2015-2020)
Figure 59. Global Engineered T Cells Revenue Share by Type in 2019
Figure 60. Global Engineered T Cells Market Share Forecast by Type (2021-2025)
Figure 61. Global Tumor Infiltrating Lymphocytes Revenue Growth Rate (2015-2020)
Figure 62. Global T Cell Receptor {TCR} Revenue Growth Rate (2015-2020)
Figure 63. Global Chimeric Antigen Receptor (CAR) Revenue Growth Rate (2015-2020)
Figure 64. Global Engineered T Cells Revenue Share by Application (2015-2020)
Figure 65. Global Engineered T Cells Revenue Share by Application in 2019
Figure 66. Global Engineered T Cells Market Share Forecast by Application (2021-2025)
Figure 67. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 68. Global Cancer Research Centers Revenue Growth Rate (2015-2020)
Figure 69. Global Clinics Revenue Growth Rate (2015-2020)
Figure 70. Global Engineered T Cells Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global Engineered T Cells Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global Engineered T Cells Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America Engineered T Cells Revenue Market Forecast (2021-2025)
Figure 74. Europe Engineered T Cells Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific Engineered T Cells Revenue Market Forecast (2021-2025)
Figure 76. South America Engineered T Cells Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa Engineered T Cells Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
エンジニアードT細胞の世界市場（～2026年） Market Analysis and Insights: Global Engineered T Cells Market The global Engineered T Cells market size is projected to reach US$ 336.1 million by 2026, from US$ 263.2 million in 2020, at a CAGR of 26.4%% during 2021-2026. Global Engineered T Cells Scope and Market Size Engineered T Cells market is…- 循環腫瘍細胞（CTC）＆がん幹細胞の世界市場（～2026年） The tumor cells which have shed into lymphatic system and circulated over the body through blood circulation are called as circulating tumor cells. Circulating tumor cells may comprise seeds for metastasis. Stem cells are the type of cells that can differentiate into specialized cells and have the c…
- 循環腫瘍細胞（CTC）予後技術の世界市場（～2026年） Circulating tumor cells (CTCs) are specialized rare cells, which have been shed from a primary solid tumor of the body and circulate in the vasculature system of the body, eventually causing metastasis. CTCs act as the seeds for successive development of additional metastatic tumors in distant organ…
- ヒト間葉系幹細胞（hMSC）の世界市場（～2026年） Human mesenchymal stem cells (hMSC) are multipotent stromal cells that can differentiate into a variety of cell types. Market Analysis and Insights: Global Human Mesenchymal Stem Cells (hMSC) Market The global Human Mesenchymal Stem Cells (hMSC) market size is projected to reach US$ XX million by 20…
- 微生物燃料電池（MFC）の世界市場（～2026年） Microbial Fuel Cell (MFC) is a bio-electrochemical system that produces electric current by using bacteria. MFC is essentially a device that converts chemical energy into electrical energy by using bacteria or microorganisms. MFC has gained attention due to its capability to produce electricity from…